13th Asia Regulatory Conference

Building future-ready regulatory systems to accelerate scientific innovation and patient access

How Asia is advancing reliance, convergence and regulatory innovation,

10 - 12 November 2026
Online 07:30 - 10:30 CET
Online 07:30 - 10:30 CET

How Asia is advancing reliance, convergence and regulatory innovation

For more than a decade, the Asia Regulatory Conference has provided a platform for meaningful, solutions-oriented dialogue on the future of regulatory systems in the region.

The 2026 edition of the conference examined how greater international collaboration, regulatory reliance, and convergence can help regulatory authorities respond to growing demands, make the best use of available expertise and resources, and keep pace with rapid scientific and technological progress.

Key focus areas

Reliance: Strengthen understanding of the value of regulatory reliance and identify meaningful approaches to monitoring its implementation and impact.

Harmonization: Highlight the value of membership in the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) and the implementation of ICH guidelines in support of globally harmonized regulatory standards.

Advanced therapies: Advance more harmonized and collaborative regulatory approaches for advanced therapies across the region.

Digitalization: Demonstrate how digitalization can strengthen regulatory systems through the exchange of good practices and practical implementation examples.

IFPMA, in partnership with our member association PharmaGroup Vietnam, hosted the 13th Asia Regulatory Conference from 10 to 12 November 2026. We brought together regulatory authorities, international organizations, industry experts, academia, and other stakeholders from Asia and beyond.

Event partner

Pharma Group Vietnam logo

Pharma Group